Philip Hall
Novartis
2 Papers
26 Citations
Philip Hall is an academic researcher from Novartis. The author has contributed to research in topics: Tripeptide. The author has an hindex of 2, co-authored 2 publications.
Chat about Author
Papers
A synthesis of the C1N12 tripeptide fragment of sanglifehrin A
TL;DR: In this paper, the synthesis of the C1N12 tripeptide of the novel immunosuppressant sanglifehrin A was described, and the Evans oxazolidinone methodology was used to install the C8 stereocentre of the meta-tyrosine subunit.
30